| DIVISLAB | | | 6,138 140.10 2.34% |
Insider
MPharm Pharm is CEO Director of Divis Laboratories Limited
| Age | 48 |
| Address | Divi Towers, Hyderabad, India, 500032 |
| Phone | 91 40 6696 6300 |
| Web | https://www.divislabs.com |
Divis Laboratories Management Efficiency
The company has return on total asset
(ROA) of
0.0912 % which means that it generated a profit of $0.0912 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1391 %, meaning that it generated $0.1391 on every $100 dollars invested by stockholders. Divis Laboratories' management efficiency ratios could be used to measure how well Divis Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Divis Laboratories'
Total Assets are projected to increase significantly based on the last few years of reporting. The current year's
Non Current Assets Total is expected to grow to about 60.8
B, whereas
Net Tangible Assets are forecasted to decline to about 70
B.
Divis Laboratories Limited has accumulated 30
M in total debt. Debt can assist Divis Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Divis Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Divis Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Divis to invest in growth at high rates of return. When we think about Divis Laboratories' use of debt, we should always consider it together with cash and equity.
Divis Laboratories Limited (DIVISLAB) is traded on National Stock Exchange of India in India and employs 9,741 people. Divis Laboratories is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Divis Laboratories Leadership Team
Elected by the shareholders, the Divis Laboratories' board of directors comprises two types of representatives: Divis Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Divis. The board's role is to monitor Divis Laboratories' management team and ensure that shareholders' interests are well served. Divis Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Divis Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Y BE, Global Head | |
| LLB MCom, VP Officer | |
| Madhusudana Divi, Director Director | |
| Srinivasa MPharm, Chief Technologist | |
| MPharm Pharm, CEO Director | |
| BTech MBA, Vice Marketing | |
| Devendra MSc, WholeTime Director | |
| Nilima Divi, Wholetime Commercial | |
| BCom FCMA, Chief Officer | |
| Satish Choudhury, Company Officer | |
| Dr Pharm, MD Director | |
| Venkata BSc, Executive Director | |
| Ramesh BSc, Chief Technologist | |
Divis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Divis Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Divis Stock
Divis Laboratories financial ratios help investors to determine whether Divis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Divis with respect to the benefits of owning Divis Laboratories security.